Clinical Trial Update: Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 dose-finding trial comparing latanoprost to a novel glaucoma treatment, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma
• Pigmentary Glaucoma
• Pseudoexfoliative Glaucoma

Drugs mentioned

• Latanoprost (Latanoprost)
• Novel glaucoma treatment

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-08-27